HNB
BEAM icon

Huntington National Bank’s Beam Therapeutics BEAM Stock Holding History

Huntington National Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-53
Closed -$1.27K – 3870
2023
Q3 		$1.27K Buy
+53
New +$1.42K ﹤0.01% 2173
2021
Q1 		– Sell
-215
Closed -$18K – 1616
2020
Q4 		$18K Buy
+215
New +$10.6K ﹤0.01% 1151

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Huntington National Bank's BEAM Position: Q4 2023 in Review

Huntington National Bank sold out of Beam Therapeutics (BEAM) in Q4 2023, closing a stake of 53 shares — an estimated $1.27K sold.

Huntington National Bank first reported a position in BEAM in Q4 2020 and held it in 2 quarters. The position peaked at $18K in Q4 2020. 185 funds tracked by Wall St. Rank hold BEAM as of Q4 2023.

  • Huntington National Bank reported no remaining Beam Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Huntington National Bank sold 53 Beam Therapeutics shares in Q4 2023, an estimated $1.27K.
  • Huntington National Bank first reported a position in Beam Therapeutics in Q4 2020 and held it in 2 quarters.
  • Huntington National Bank's Beam Therapeutics position peaked at $18K in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2023.

Based on Huntington National Bank's 13F filing for Q4 2023, filed 7 Feb 2024.